Apnimed

APMDNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$589.076 M

$14.15 -7.52%

Close of 6 Nov 2026

As of 6 Nov 2026, Apnimed (APMD) has a market capitalization of $589.1M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

41,630,779

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →

#178Immix BiopharmaIMMX$597.3M
#179Olema PharmaceuticalsOLMA$593.7M
#180ApnimedAPMD$589.1M
#181Arbutus BiopharmaABUS$561.8M
#182Bicara TherapeuticsBCAX$542.6M

Insiders buying

All insider buying →

2 open-market purchases by officers and directors of Apnimed, worth $5.20M. Grants and option exercises are excluded.

Morningside Venture Investments Ltd$5.00M
312,500 shares at $16.00 on 3 Aug 2026 · filed 5 Aug 2026
Paul J. Sekhri$200.0K
12,500 shares at $16.00 on 3 Aug 2026 · filed 3 Aug 2026

What if Apnimed were worth as much as…

Open the what-if tool →

Gold $28.2T

$678,269.17

Per share 47,934× higher

Bitcoin $1.53T

$36,699.96

Per share 2,594× higher

Apple $5.02T

$120,482.55

Per share 8,515× higher

Or at a round number

$1.00B $2.00B $5.00B $10.0B

Where these numbers come from

Share counts and financials for Apnimed are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.